CCN4 and neoplasm: To confirm the key role of WISP-1 in the anti-tumor progression and antimetastatic effects of ApoSQ-CAF CM in vivo, an anti-WISP-1 neutralizing antibody or IgG isotype control was added to the CM for 2 h before injection into mice.